Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy

J Dermatolog Treat. 2022 Feb;33(1):592. doi: 10.1080/09546634.2020.1769828. Epub 2020 May 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biological Products* / therapeutic use
  • COVID-19*
  • Hidradenitis Suppurativa* / drug therapy
  • Humans
  • Referral and Consultation
  • SARS-CoV-2

Substances

  • Biological Products